# FDA 483 - AndersonBrecon Inc. - February 25, 2022

Source: https://www.globalkeysolutions.net/records/483/andersonbrecon-inc/4335f23a-d6f2-4fab-9453-4501d889b30d

> FDA 483 for AndersonBrecon Inc. on February 25, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: AndersonBrecon Inc.
- Inspection Date: 2022-02-25
- Product Type: drugs
- Office Name: Chicago District Office
- Summary: AndersonBrecon Inc. dba PCI Pharma Services in Rockford, IL, a drug packaging and labeling facility, was cited for failing to follow written production and process control procedures. The inspection revealed deficiencies in batch record review, where a required temperature report was missing, and in deviation investigations, which were not closed within the established 30-day timeframe. These issues indicate a lack of adherence to established quality control processes.

## Related Officers

- [Laurel A. Beer](https://www.globalkeysolutions.net/people/laurel-a-beer/0ac1e74f-0ff6-4db6-a0e8-0c3fb013720e)

Company: https://www.globalkeysolutions.net/companies/andersonbrecon-inc/aefafff0-9d39-4b82-8ebb-44c17e5d0f6d

Office: https://www.globalkeysolutions.net/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669